Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RNLX

Renalytix (RNLX)

Renalytix PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RNLX
DateTimeSourceHeadlineSymbolCompany
07/11/20247:00AMGlobeNewswire Inc.Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond USNASDAQ:RNLXRenalytix PLC
06/27/20246:30PMGlobeNewswire Inc.Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting DeterminationNASDAQ:RNLXRenalytix PLC
06/14/20249:31AMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:RNLXRenalytix PLC
06/14/20247:00AMGlobeNewswire Inc.Medicare Issues Final Coverage Determination for kidneyintelX.dkdNASDAQ:RNLXRenalytix PLC
06/12/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
06/05/20244:31PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RNLXRenalytix PLC
05/28/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
05/15/202410:09AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RNLXRenalytix PLC
05/15/20249:23AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
05/15/20247:20AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNLXRenalytix PLC
05/15/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
05/15/20247:00AMGlobeNewswire Inc.Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
05/09/20247:00AMGlobeNewswire Inc.Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15NASDAQ:RNLXRenalytix PLC
04/08/20247:00AMGlobeNewswire Inc.Renalytix Announces Financing with Expected Size of up to $4 MillionNASDAQ:RNLXRenalytix PLC
03/14/20247:00AMGlobeNewswire Inc.KidneyIntelXâ„¢ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)NASDAQ:RNLXRenalytix PLC
02/15/20247:00AMGlobeNewswire Inc.Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
02/15/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
02/14/20244:31PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNLXRenalytix PLC
02/09/20249:00AMGlobeNewswire Inc.Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:RNLXRenalytix PLC
01/17/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
01/10/20247:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
01/10/20247:00AMGlobeNewswire Inc.New published data demonstrates KidneyIntelXâ„¢ has broad implications for winning war on chronic kidney diseaseNASDAQ:RNLXRenalytix PLC
12/29/20234:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
11/17/20234:01PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RNLXRenalytix PLC
11/14/20237:00AMGlobeNewswire Inc.Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
11/07/20237:00AMGlobeNewswire Inc.Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14NASDAQ:RNLXRenalytix PLC
11/03/20234:04PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RNLXRenalytix PLC
10/24/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
10/06/20237:00AMGlobeNewswire Inc.US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to RenalytixNASDAQ:RNLXRenalytix PLC
09/28/20237:00AMGlobeNewswire Inc.Renalytix Reports Full Year Fiscal 2023 ResultsNASDAQ:RNLXRenalytix PLC
 Showing the most relevant articles for your search:NASDAQ:RNLX